- Home
- FRPH vs EYPT Comparison
FRPH vs EYPT Comparison
Compare FRPH & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- EYPT
- Stock Information
- Founded
- FRPH 1986
- EYPT 1987
- Country
- FRPH United States
- EYPT United States
- Employees
- FRPH N/A
- EYPT N/A
- Industry
- FRPH Real Estate
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- FRPH Finance
- EYPT Industrials
- Exchange
- FRPH Nasdaq
- EYPT Nasdaq
- Market Cap
- FRPH 576.6M
- EYPT 489.4M
- IPO Year
- FRPH N/A
- EYPT 2005
- Fundamental
- Price
- FRPH $30.54
- EYPT $7.69
- Analyst Decision
- FRPH
- EYPT Strong Buy
- Analyst Count
- FRPH 0
- EYPT 8
- Target Price
- FRPH N/A
- EYPT $25.71
- AVG Volume (30 Days)
- FRPH 27.0K
- EYPT 665.0K
- Earning Date
- FRPH 03-05-2025
- EYPT 03-06-2025
- Dividend Yield
- FRPH N/A
- EYPT N/A
- EPS Growth
- FRPH 45.62
- EYPT N/A
- EPS
- FRPH 0.40
- EYPT N/A
- Revenue
- FRPH $31,414,000.00
- EYPT $45,713,000.00
- Revenue This Year
- FRPH N/A
- EYPT N/A
- Revenue Next Year
- FRPH N/A
- EYPT N/A
- P/E Ratio
- FRPH $76.97
- EYPT N/A
- Revenue Growth
- FRPH 4.04
- EYPT 7.50
- 52 Week Low
- FRPH $26.99
- EYPT $6.90
- 52 Week High
- FRPH $33.00
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- FRPH 54.78
- EYPT 41.66
- Support Level
- FRPH $30.50
- EYPT $7.58
- Resistance Level
- FRPH $31.39
- EYPT $8.16
- Average True Range (ATR)
- FRPH 0.59
- EYPT 0.55
- MACD
- FRPH 0.11
- EYPT -0.07
- Stochastic Oscillator
- FRPH 69.65
- EYPT 3.06
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.